pdf
Published
2022-03-22
Issue
Section
Pharmacy Practice & Practice-Based Research
Categories
License
Copyright (c) 2022 Melody Okereke, Hope Mufaro Mashavakure, Muhsinah Adesewa Abdulwasiu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?
Melody Okereke
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria
Hope Mufaro Mashavakure
Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Zimbabwe
Muhsinah Adesewa Abdulwasiu
Dora Akunyili College of Pharmacy, Igbinedion University Okada, Edo State, Nigeria
DOI: https://doi.org/10.24926/iip.v13i1.4656
Keywords: Zimbabwe, Pharmaceutical Manufacturing, COVID-19, Vaccines, Africa
Abstract
Globally, the COVID-19 pandemic has had a significant impact, given the rise in the demand for novel therapeutics such as vaccines that can be used in the treatment of COVID-19 patients. Compared to other regions of the world, gross vaccine inequity exists in Africa due to several factors tied to the acute lack of vaccines in the region. As a result, efforts are currently being made to ramp up the production of COVID-19 vaccines in the region. However, there are concerns that most countries in Africa lack the adequate pharmaceutical manufacturing capacity required to produce COVID-19 vaccines, and Zimbabwe is not an exception. This article, therefore, aims to evaluate the preparedness and readiness efforts of the Zimbabwean pharmaceutical industry in the production of COVID-19 vaccines.
